Amazon coin set to soar 25X – starting December 16th?

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

FENC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.98%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,328,516.33

Fennec Pharmaceuticals Insider Trading History Chart

Fennec Pharmaceuticals Share Price & Price History

^$5.99

▲ +0.15 (2.57%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Fennec Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2024	Rosty Raykov	Director	Sell	796	$6.04	$4,807.84	66,432
12/2/2024	Chris A Rallis	Director	Sell	6,409	$6.14	$39,351.26	52,214
11/4/2024	Rosty Raykov	Director	Sell	2,431	$4.31	$10,477.61	66,432
10/8/2024	Chris A Rallis	Director	Sell	1,406	$4.53	$6,369.18	48,623
10/1/2024	Rosty Raykov	Director	Sell	2,431	$4.94	$12,009.14	66,432
8/1/2024	Rosty Raykov	CEO	Sell	2,431	$6.25	$15,193.75	187,471
7/5/2024	Chris A Rallis	Director	Sell	1,173	$6.03	$7,073.19	46,457
7/2/2024	Rosty Raykov	CEO	Sell	2,431	$6.13	$14,902.03	187,471
6/3/2024	Rosty Raykov	CEO	Sell	2,431	$6.76	$16,433.56	187,471
5/1/2024	Rosty Raykov	CEO	Sell	2,431	$9.11	$22,146.41	187,471
4/22/2024	Adrian Haigh	COO	Sell	22,223	$9.32	$207,118.36
4/19/2024	Adrian Haigh	COO	Sell	22,222	$9.34	$207,553.48
4/17/2024	Adrian Haigh	COO	Sell	22,222	$9.91	$220,220.02	22,222
4/15/2024	Adrian Haigh	COO	Sell	22,222	$10.30	$228,886.60	22,222
4/15/2024	Chris A Rallis	Director	Sell	800	$10.45	$8,360.00	44,449
4/5/2024	Rosty Raykov	CEO	Sell	44,300	$10.75	$476,225.00	187,471
4/3/2024	Rosty Raykov	CEO	Sell	40,584	$10.78	$437,495.52	276,054
3/26/2024	Chris A Rallis	Director	Sell	2,114	$10.97	$23,190.58	40,920
3/25/2024	Robert Andrade	CFO	Sell	13,975	$11.00	$153,725.00	105,746
1/4/2024	Robert Andrade	CFO	Sell	15,000	$10.64	$159,600.00	134,721
12/28/2023	Rosty Raykov	CEO	Sell	3,656	$11.55	$42,226.80	287,471
12/26/2023	Chris A Rallis	Director	Sell	1,390	$10.90	$15,151.00	44,788
11/20/2023	Chris A Rallis	Director	Sell	269	$8.25	$2,219.25	43,034
11/8/2023	Rosty Raykov	CEO	Sell	25,044	$7.76	$194,341.44	282,587
8/18/2023	Chris A Rallis	Director	Sell	673	$7.85	$5,283.05	43,303
7/24/2023	Chris A Rallis	Director	Sell	6,796	$8.17	$55,523.32	43,976
7/6/2023	Chris A Rallis	Director	Sell	2,207	$8.47	$18,693.29	28,826
6/30/2023	Robert Andrade	CFO	Sell	7,500	$8.82	$66,150.00	124,721
6/28/2023	Robert Andrade	CFO	Sell	10,000	$8.99	$89,900.00	139,721
5/19/2023	Chris A Rallis	Director	Sell	1,758	$7.36	$12,938.88	31,033
12/30/2022	Robert Andrade	CFO	Sell	5,500	$9.61	$52,855.00	149,721
12/30/2022	Rosty Raykov	CEO	Sell	10,000	$9.62	$96,200.00	217,838
12/28/2022	Robert Andrade	CFO	Sell	11,000	$9.61	$105,710.00	160,721
12/28/2022	Rosty Raykov	CEO	Sell	13,740	$9.59	$131,766.60	232,838

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Fennec Pharmaceuticals (NASDAQ:FENC)

55.51% of Fennec Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fennec Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	14,799	$74K	0.0%	+18.7%	0.054%
11/19/2024	Barclays PLC	31,319	$0.16M	0.0%	+274.3%	0.114%
11/15/2024	Barclays PLC	31,319	$0.16M	0.0%	+274.3%	0.114%
11/15/2024	State Street Corp	328,259	$1.64M	0.0%	+2.2%	1.197%
11/14/2024	Verition Fund Management LLC	10,625	$53K	0.0%	-68.5%	0.039%
11/13/2024	BNP Paribas Financial Markets	40,016	$0.20M	0.0%	-14.7%	0.146%
11/13/2024	Advantage Alpha Capital Partners LP	52,876	$0.26M	0.1%	N/A	0.193%
8/15/2024	The Manufacturers Life Insurance Company	11,310	$69K	0.0%	N/A	0.041%
8/9/2024	WINTON GROUP Ltd	67,005	$0.41M	0.0%	N/A	0.245%
8/6/2024	Acadian Asset Management LLC	8,086	$49K	0.0%	N/A	0.030%
8/1/2024	Rhumbline Advisers	29,110	$0.18M	0.0%	+44.7%	0.107%
7/26/2024	Bank of New York Mellon Corp	68,724	$0.42M	0.0%	+42.8%	0.251%
5/15/2024	Gendell Jeffrey L	302,478	$3.36M	0.1%	+7.1%	1.107%
5/10/2024	Vanguard Group Inc.	1,013,626	$11.27M	0.0%	-11.1%	3.711%
5/8/2024	Russell Investments Group Ltd.	34,260	$0.38M	0.0%	+71,275.0%	0.125%
5/3/2024	Essex Investment Management Co. LLC	144,218	$1.60M	0.3%	N/A	0.532%
5/1/2024	BNP Paribas Financial Markets	32,769	$0.36M	0.0%	+67.7%	0.121%
4/25/2024	Eudaimonia Advisors LLC	35,359	$0.39M	0.2%	+8.2%	0.130%
2/15/2024	Gendell Jeffrey L	282,478	$3.17M	0.2%	-1.2%	1.045%
2/13/2024	Tower Research Capital LLC TRC	3,048	$34K	0.0%	+107.3%	0.011%
2/12/2024	DG Capital Management LLC	1,075,634	$12.07M	7.5%	-5.9%	3.978%
2/12/2024	AIGH Capital Management LLC	329,370	$3.70M	1.5%	-11.8%	1.218%
2/9/2024	Worth Venture Partners LLC	141,500	$1.59M	0.9%	+52.7%	0.523%
2/7/2024	Jump Financial LLC	14,100	$0.16M	0.0%	N/A	0.052%
2/1/2024	Eudaimonia Advisors LLC	32,686	$0.37M	0.2%	+90.8%	0.121%
1/29/2024	Hartford Financial Management Inc.	47,348	$0.53M	0.1%	+4.4%	0.175%
11/13/2023	Gendell Jeffrey L	285,992	$2.15M	0.1%	+0.9%	1.074%
11/13/2023	AIGH Capital Management LLC	373,526	$2.81M	1.3%	+6.9%	1.402%
10/27/2023	Allspring Global Investments Holdings LLC	6,705	$50K	0.0%	N/A	0.025%
9/21/2023	Barclays PLC	3,635	$32K	0.0%	-62.5%	0.014%
8/14/2023	Wexford Capital LP	26,414	$0.23M	0.0%	N/A	0.099%
8/11/2023	Gendell Jeffrey L	283,413	$2.50M	0.2%	+12.3%	1.067%
8/11/2023	Cibc World Market Inc.	80,568	$0.71M	0.0%	-29.9%	0.303%
8/11/2023	DG Capital Management LLC	1,074,654	$9.49M	4.2%	-14.0%	4.045%
8/4/2023	American International Group Inc.	8,735	$77K	0.0%	N/A	0.033%
7/27/2023	Hartford Financial Management Inc.	45,348	$0.40M	0.1%	+9.7%	0.171%
7/26/2023	HighMark Wealth Management LLC	3,000	$26K	0.0%	N/A	0.011%
7/19/2023	Eudaimonia Advisors LLC	17,130	$0.15M	0.1%	N/A	0.065%
7/14/2023	Trellus Management Company LLC	10,561	$93K	0.1%	-11.0%	0.040%
5/16/2023	Solas Capital Management LLC	1,284,543	$10.69M	5.7%	+2.6%	4.863%
5/15/2023	AIGH Capital Management LLC	162,154	$1.35M	0.5%	N/A	0.614%
5/15/2023	Gendell Jeffrey L	252,286	$2.10M	0.2%	+64.8%	0.955%
5/12/2023	Harbert Fund Advisors Inc.	466,869	$3.88M	2.6%	+47.3%	1.768%
5/11/2023	Toronto Dominion Bank	25,400	$0.20M	0.0%	N/A	0.096%
5/11/2023	DG Capital Management LLC	1,250,096	$10.40M	5.8%	+22.3%	4.733%
5/11/2023	Tamarack Advisers LP	149,200	$1.24M	0.5%	-30.0%	0.565%
5/3/2023	Jump Financial LLC	14,220	$0.12M	0.0%	-32.3%	0.054%
4/28/2023	Janney Montgomery Scott LLC	20,000	$0.17M	0.0%	N/A	0.076%
4/25/2023	Hartford Financial Management Inc.	41,348	$0.34M	0.1%	+3.8%	0.157%
4/20/2023	Trellus Management Company LLC	11,861	$99K	0.1%	N/A	0.045%
2/14/2023	683 Capital Management LLC	300,000	$2.88M	0.2%	-22.0%	1.136%
2/14/2023	Gendell Jeffrey L	153,070	$1.47M	0.1%	N/A	0.580%
2/13/2023	Harbert Fund Advisors Inc.	316,949	$3.04M	2.4%	+67.0%	1.200%
2/13/2023	Tamarack Advisers LP	213,000	$2.05M	1.1%	+21.7%	0.807%
2/10/2023	Opaleye Management Inc.	272,200	$2.61M	0.9%	N/A	1.031%
11/16/2022	Tamarack Advisers LP	175,000	$1.42M	0.8%	N/A	0.667%
11/14/2022	683 Capital Management LLC	384,824	$3.12M	0.2%	-9.5%	1.467%
10/25/2022	Hartford Financial Management Inc.	39,848	$0.32M	0.1%	+14.3%	0.152%
5/11/2022	DG Capital Management LLC	1,210,638	$6.78M	1.4%	+4.4%	4.649%
2/15/2022	683 Capital Management LLC	709,300	$3.12M	0.1%	-36.1%	2.727%
1/27/2022	Hartford Financial Management Inc.	34,848	$0.15M	0.0%	+20.8%	0.134%
11/16/2021	Millennium Management LLC	257,621	$2.43M	0.0%	-36.4%	0.990%
11/15/2021	Ancora Advisors LLC	6,000	$57K	0.0%	N/A	0.023%
11/12/2021	Harbert Fund Advisors Inc.	174,750	$1.65M	0.6%	+44.6%	0.672%
11/12/2021	DG Capital Management LLC	618,451	$5.83M	1.2%	+5.0%	2.378%
11/9/2021	BlackRock Inc.	57,321	$0.54M	0.0%	-8.3%	0.220%
11/8/2021	Russell Investments Group Ltd.	31,728	$0.30M	0.0%	-71.8%	0.122%
10/19/2021	Belvedere Trading LLC	17,790	$0.16M	0.0%	N/A	0.068%
9/17/2021	Virtu Financial LLC	13,454	$98K	0.0%	+12.9%	0.052%
9/3/2021	Parametric Portfolio Associates LLC	22,435	$0.16M	0.0%	-18.4%	0.086%
8/17/2021	Millennium Management LLC	404,772	$2.95M	0.0%	N/A	1.556%
8/16/2021	Tibra Equities Europe Ltd	46,300	$0.34M	0.1%	N/A	0.178%
8/16/2021	Goldman Sachs Group Inc.	13,398	$98K	0.0%	-36.4%	0.052%
8/16/2021	Harbert Fund Advisors Inc.	120,851	$0.88M	0.5%	N/A	0.465%
8/13/2021	Renaissance Technologies LLC	20,284	$0.15M	0.0%	N/A	0.078%
8/13/2021	Geode Capital Management LLC	17,926	$0.13M	0.0%	-89.4%	0.069%
8/12/2021	DG Capital Management LLC	588,773	$4.29M	0.9%	N/A	2.264%
8/12/2021	JPMorgan Chase & Co.	20,021	$0.15M	0.0%	-12.6%	0.077%
8/12/2021	Ergoteles LLC	92,340	$0.67M	0.0%	N/A	0.355%
8/5/2021	GSA Capital Partners LLP	68,724	$0.50M	0.1%	+88.4%	0.264%
8/4/2021	Russell Investments Group Ltd.	112,584	$0.82M	0.0%	-42.7%	0.433%
8/2/2021	Advisor Group Holdings Inc.	12,370	$90K	0.0%	+359.9%	0.048%
7/31/2021	Hartford Financial Management Inc.	28,848	$0.21M	0.1%	-14.8%	0.111%
5/19/2021	Virtu Financial LLC	11,917	$74K	0.0%	N/A	0.046%
5/17/2021	AQR Capital Management LLC	12,977	$81K	0.0%	-21.8%	0.050%
5/17/2021	Nuveen Asset Management LLC	101,369	$0.63M	0.0%	-4.4%	0.390%
5/17/2021	Goldman Sachs Group Inc.	21,057	$0.13M	0.0%	-14.6%	0.081%
5/13/2021	Barclays PLC	18,194	$0.11M	0.0%	+159.0%	0.070%
5/12/2021	Northern Trust Corp	182,107	$1.13M	0.0%	-10.7%	0.700%
5/12/2021	JPMorgan Chase & Co.	22,914	$0.14M	0.0%	+137.0%	0.088%
5/12/2021	UBS Group AG	40,569	$0.25M	0.0%	+1,042.8%	0.156%
5/10/2021	Russell Investments Group Ltd.	196,477	$1.22M	0.0%	-9.9%	0.756%
5/10/2021	GSA Capital Partners LLP	36,473	$0.23M	0.0%	N/A	0.140%
5/7/2021	BlackRock Inc.	1,132,769	$7.04M	0.0%	+2.3%	4.356%
4/14/2021	Hartford Financial Management Inc.	33,848	$0.21M	0.1%	-12.9%	0.130%
3/26/2021	Susquehanna International Group LLP	11,368	$85K	0.0%	-68.8%	0.044%
2/19/2021	JPMorgan Chase & Co.	9,670	$72K	0.0%	+21.3%	0.037%
2/16/2021	Nuveen Asset Management LLC	106,049	$0.79M	0.0%	+2.4%	0.408%
2/16/2021	Charles Schwab Investment Management Inc.	45,870	$0.34M	0.0%	+6.7%	0.176%
2/12/2021	Raymond James Financial Services Advisors Inc.	28,325	$0.21M	0.0%	+13.3%	0.109%

Data available starting January 2016

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

Today's Range

Now: $5.99

$5.73

$6.00

50 Day Range

MA: $5.12

$3.99

$6.24

52 Week Range

Now: $5.99

$3.96

$11.92

Volume

172,912 shs

Average Volume

118,721 shs

Market Capitalization

$164.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Fennec Pharmaceuticals?: Fennec Pharmaceuticals' top insider investors include:
Rosty Raykov (CEO)
Robert Andrade (CFO)
Rosty Raykov (Director)
Chris A Rallis (Director)
Adrian Haigh (COO)
Learn More about top insider investors at Fennec Pharmaceuticals.
Who are the major institutional investors of Fennec Pharmaceuticals?: Fennec Pharmaceuticals' top institutional shareholders include:
State Street Corp — 1.20%
Advantage Alpha Capital Partners LP — 0.19%
BNP Paribas Financial Markets — 0.15%
Barclays PLC — 0.11%
Barclays PLC — 0.11%
Franklin Resources Inc. — 0.05%
Learn More about top institutional investors of Fennec Pharmaceuticals stock.
Which institutional investors are selling Fennec Pharmaceuticals stock?: During the last quarter, FENC stock was sold by these institutional investors:
Verition Fund Management LLC
BNP Paribas Financial Markets
In the last year, company insiders that have sold Fennec Pharmaceuticals company stock include:
Rosty Raykov (CEO)
Robert Andrade (CFO)
Rosty Raykov (Director)
Chris A Rallis (Director)
Adrian Haigh (COO)
Learn More investors selling Fennec Pharmaceuticals stock.
Which institutional investors are buying Fennec Pharmaceuticals stock?: In the last quarter, FENC stock was bought by institutional investors including:
Advantage Alpha Capital Partners LP
Barclays PLC
Barclays PLC
State Street Corp
Franklin Resources Inc.